Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |